In a move that elicited rare agreement among groups representing consumers and the pharmaceutical industry, the European Commission proposed various steps to accelerate the approval of drugs and devices by European Union member states.
Although the proposal follows more than 20 years of voluntary cooperation, the commission is hoping to memorialize the effort in order to streamline procedures that so medical products can reach patients faster and companies can more easily seek regulatory approvals.
About the Author Reprints
